Purinergic receptors and calcium signalling in human pancreatic duct cell lines

Cellular Physiology and Biochemistry

Volumn 22, Issue 1-4, 2008, Pages 157-168

  Hansen, Mette R ^a   Krabbe, Simon ^a   Novak, Ivana ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ATP release; P2X4 receptor; P2X7 receptor; Pancreatic ducts; Purinergic receptors

Indexed keywords

2',3' O BENZOYLBENZOYL ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; IVERMECTIN; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y11 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y13 RECEPTOR; PURINERGIC P2Y14 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; OSCILLATION; PANCREAS DUCT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

EID: 51149095045     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149793     Document Type: Article

References (52)

1. Burnstock G: Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007;87:659-797.
2. Novak I: ATP as a signaling molecule - the exocrine focus. News Physiol Sci 2003;18:12-17.
3. Leipziger J: Control of epithelial transport via luminal P2 receptors. Am J Physiol Renal Physiol 2003;284:F419-F432.
4. Schwiebert EM, Zsembery A: Extracellular ATP as a signaling molecule for epithelial cells. Biochim Biophys Acta 2002;1615:7-32.
5. North RA: Molecular physiology of P2X receptors. Physiol Rev 2002;82:1013-1067.
6. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA: International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006;58:281-341.
7. Khakh BS, North RA: P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006;442:527-532.
8. Sørensen CE, Novak I: Visualization of ATP release in pancreatic acini in response to cholinergic stimulus. Use of fluorescent probes and confocal microscopy. J Biol Chem 2001;276:32925-32932.
9. Yegutkin GG, Samburski SS, Jalkalen S, Novak I: ATP-consuming and ATP-generating enzymes secreted by pancreas. J Biol Chem 2006;281:29441-29447.
10. Henriksen KL, Novak I: Effect of ATP on intracellular pH in pancreatic ducts involves P2X7 receptors. Cell Physiol Biochem 2003;13:93-102.
11. + conductance, and P2X stimulates cation conductance. J Biol Chem 1999;274:31784-31791.
12. Luo X, Zheng W, Yan M, Lee MG, Muallem S: Multiple functional P2X and P2Y receptors in the luminal and basolateral membranes of pancreatic duct cells [see comments]. Am J Physiol 1999;277:C205-C215.
13. Nguyen TD, Moody MW, Savard CE, Lee SP: Secretory effects of ATP on nontransformed dog pancreatic duct epithelial cells. Am J Physiol 1998;275:G104-G113.
14. Nguyen TD, Meichle S, Kim US, Wong T, Moody MW: P2Y11, a purinergic receptor acting via cAMP, mediates secretion by pancreatic duct epithelial cells. Am J Physiol Gastrointest Liver Physiol 2001;280:G795-G804.
15. 2+ increase determines the type of secretory mechanism activated in dog pancreatic duct epithelial cells. J Physiol 2006;576:163-178.
16. Ishiguro H, Naruse S, Kitagawa M, Hayakawa T, Case RM, Steward MC: Luminal ATP stimulates fluid and HCO3-secretion in guinea-pig pancreatic duct. J Physiol (Lond) 1999;519:551-558.
17. Coutinho-Silva R, Parsons M, Robson T, Lincoln J, Burnstock G: P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol Cell Endocrinol 2003;204:141-154.
18. Coutinho-Silva R, Parsons M, Robson T, Burnstock G: Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing. Cell Tissue Res 2001;306:373-383.
19. Novak I: Purinergic receptors in the endocrine and exocrine pancreas. Purinergic Signal 2008;(doi 10.1007/s11302-007-9087-6).
20. - channels can substitute for CFTR in stimulation of pancreatic duct bicarbonate secretion. FASEB J 2000;14:2345-2356.
21. - currents by UTP and ATP in CFPAC-1 cells. Pflugers Arch 1994;426:534-541.
22. Chan HC, Cheung WT, Leung PY, Wu LJ, Chew SB, Ko WH, Wong PY: Purinergic regulation of anion secretion by cystic fibrosis pancreatic duct cells. Am J Physiol 1996;271:C469-C477.
23. - - dependent HCO3 transport in pancreatic duct cells. J Biol Chem 2003;278:200-207.
24. O'Reilly CM, O'Farrell AM, Ryan MP: Purinoceptor activation of chloride transport in cystic fibrosis and CFTR-transfected pancreatic cell lines. Br J Pharmacol 1998;124:1597-1606.
25. Szucs A, Demeter I, Burghardt B, Ovari G, Case RM, Steward MC, Varga G: Vectorial bicarbonate transport by Capan-1 cells: a model for human pancreatic ductal secretion. Cell Physiol Biochem 2006;18:253-264.
26. Kunzli BM, Berberat PO, Giese T, Csizmadia E, Kaczmarek E, Baker C, Halaceli I, Buchler MW, Friess H, Robson SC: Upregulation of CD39/NTPDases and P2 Receptors in Human Pancreatic Disease. Am J Physiol Gastrointest Liver Physiol 2007;292:G223-G230.
27. Kunzli BM, Nuhn P, Enjyoji K, Banz Y, Smith RN, Csizmadia E, Schuppan D, Berberat PO, Friess H, Robson SC: Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Gastroenterology 2008;134:292-305.
28. Kopelman H, Gauthier C, Bornstein M: Antisense oligodeoxynucleotide to the cystic fibrosis transmembrane conductance regulator inhibits cyclic AMP-activated but not calcium-activated cell volume reduction in a human pancreatic duct cell line. J Clin Invest 1993;91:1253-1257.
29. Steagall WK, Kelley TJ, Marsick RJ, Drumm ML: Type II protein kinase A regulates CFTR in airway, pancreatic, and intestinal cells. Am J Physiol 1998;274:C819-C826.
30. Schoumacher RA, Ram J, Iannuzzi MC, Bradbury NA, Wallace RW, Hon CT, Kelly DR, Schmid SM, Gelder FB, Rado TA, Frizzell RA: A cystic fibrosis pancreatic adenocarcinoma cell line. Proc Natl Acad Sci USA 1990;87:4012-4016.
31. Hug M, Pahl C, Novak I: Effect of ATP, carbachol and other agonists on intracellular calcium activity and membrane voltage of pancreatic ducts. Pflügers Arch 1994;426:412-418.
32. Hollande E, Salvador-Cartier C, Alvarez L, Fanjul M: Expression of a wild-type CFTR maintains the integrity of the biosynthetic/secretory pathway in human cystic fibrosis pancreatic duct cells. J Histochem Cytochem 2005;53:1539-1552.
33. Madden ME, Sarras MP, Jr.: Morphological and biochemical characterization of a human pancreatic ductal cell line (PANC-1). Pancreas 1988;3:512-528.
34. Nielsen SK, Møllgård K, Clement CA, Thorsteinsson RI, Yoder BK, Pedersen LB, Novak I, Christensen ST: Characterization of primary cilia and hedhegog signaling during development of the human pancreas and in human pancreatioc duct cancer cell lines. Dev Dynamics 2008; in press.
35. Christoffersen BC, Hug MJ, Novak I: Different purinergic receptors lead to intracellular calcium increases in pancreatic ducts. Pflügers Arch Eur J Physiol 1998;436:33-39.
36. Stam NJ, Klomp J, van de Huevel M, Olijve W: Molecular cloning and characterization of a novel orphan receptor (P2P) expressed in human pancreas that shows high structural homology to the P2U purinoceptor. FEBS Lett 1996;384:260-264.
37. Khakh BS, Proctor WR, Dunwiddie TV, Labarca C, Lester HA: Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci 1999;19:7289-7299.
38. Priel A, Silberberg SD: Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol 2004;123:281-293.
39. Novak I, Hede SE, Hansen MR: Adenosine receptors in rat and human pancreatic ducts stimulate chloride transport. Pflugers Arch 2007;456:437-447.
40. Novak I, Nitschke R, Amstrup J: Purinergic receptors have different effects in rat exocrine pancreas. Calcium signals monitored by Fura-2 in confocal microscope. Cell Physiol Biochem 2002;12:83-92.
41. Tenneti L, Gibbons SJ, Talamo BR: Expression and trans-synaptic regulation of P2x4 and P2z receptors for extracellular ATP in parotid acinar cells. Effects of parasympathetic denervation. J Biol Chem 1998;273:26799-26808.
42. Berridge MJ, Bootman MD, Roderick HL: Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003;4:517-529.
43. - current recording in single pancreatic acinar cells. EMBO J 1990;9:697-704.
44. 2+ oscillations in pancreatic acinar cells. EMBO J 1994;13:2038-2043.
45. 2+ release: the roles of nicotinic acid adenine dinucleotide phosphate, cyclic ADP-ribose and inositol trisphosphate. EMBO J 2000;19:2549-2557.
46. 2+ -activated ion channels in exocrine acinar cells. Cell Calcium 2005;38:171-200.
47. Bowser DN, Khakh BS: Vesicular ATP is the predominant cause of intercellular calcium waves in astrocytes. J Gen Physiol 2007;129:485-491.
48. Iadecola C, Nedergaard M: Glial regulation of the cerebral microvasculature. Nat Neurosci 2007;10:1369-1376.
49. Guo C, Masin M, Qureshi OS, Murrell-Lagnado RD: Evidence for functional P2X4/P2X7 heteromeric receptors. Mol Pharmacol 2007;72:1447-1456.
50. Royle SJ, Qureshi OS, Bobanovic LK, Evans PR, Owen DJ, Murrell-Lagnado RD: Non-canonical YXXGPhi endocytic motifs: recognition by AP2 and preferential utilization in P2X4 receptors. J Cell Sci 2005;118:3073-3080.
51. 2+ influx. Biochem J 2003;374:51-61.
52. Brown DA, Bruce JI, Straub SV, Yule DI: cAMP potentiates ATP-evoked calcium signaling in human parotid acinar cells. J Biol Chem 2004;279:39485-39494.